THYMOMA
Clinical trials for THYMOMA explained in plain language.
Never miss a new study
Get alerted when new THYMOMA trials appear
Sign up with your email to follow new studies for THYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for rare thymus cancers after first-line failure
Disease control Recruiting nowThis study tests a combination of two drugs, tislelizumab and anlotinib, in 20 people with thymoma or thymic carcinoma whose cancer worsened after initial chemotherapy (with or without immunotherapy). The goal is to see if this second-line treatment can shrink or control tumors. …
Matched conditions: THYMOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 17, 2026 04:30 UTC
-
New drug hope for rare thymus cancers after standard treatments fail
Disease control Recruiting nowThis study tests a drug called sacituzumab govitecan in adults with advanced thymoma or thymic carcinoma that has worsened after at least one prior treatment. Participants receive the drug intravenously once weekly for two weeks, then a week off, and continue until the cancer pro…
Matched conditions: THYMOMA
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated May 17, 2026 04:28 UTC
-
Could extra radiation after thymoma surgery boost survival?
Disease control Recruiting nowThis study looks at whether giving radiation therapy after completely removing a thymoma tumor (stage II or III) helps people live longer without the cancer coming back. About 238 adults aged 18-75 who had surgery within the past 3 months will be randomly assigned to receive eith…
Matched conditions: THYMOMA
Phase: NA • Sponsor: Fudan University • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
Tissue bank study aims to unlock secrets of rare cancers
Knowledge-focused Recruiting nowThis study collects blood, urine, and tumor samples from up to 1,000 people with malignant mesothelioma and other cancers that express mesothelin. The goal is to build a tissue bank for future research into these diseases. Participants are followed over time to track their health…
Matched conditions: THYMOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC